The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Clovis Oncology; CureVac; Eisai; Genomic Health; Immunomedics (Inst); Janssen-Cilag; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Celgene; CureVac; Eisai; Genomic Health; Immunomedics (Inst); Janssen-Cilag; Novartis; Pfizer; Roche (Inst); Tesaro; Vaccibody (Inst)
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Tesaro (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche
 
Honoraria - Lilly; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Daiichi Sankyo; Hexal; Lilly; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
GAIN-2: Neo-/adjuvant phase III trial to compare intense dose-dense chemotherapy (CT) to tailored dose-dense CT in patients (pts) with high risk early breast cancer (EBC): Results on safety and interim invasive disease-free survival (iDFS).
 
Volker Moebus
Honoraria - Amgen; AstraZeneca; Celgene; Myelo Therapeutics GmbH; Roche Pharma AG
Consulting or Advisory Role - Amgen; Myelo Therapeutics GmbH; Roche Pharma AG
 
Hans-Joachim Lueck
No Relationships to Disclose
 
Ekkehart Ladda
No Relationships to Disclose
 
Peter Klare
No Relationships to Disclose
 
Marcus Schmidt
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AMGEN; AstraZeneca; Myelo Therapeutics GmbH; Novartis; Pantarhei Bioscience; Pfizer; Roche
Research Funding - AstraZeneca (Inst); BioNTech (Inst); Myelo Therapeutics GmbH (Inst); Pantarhei Bioscience (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Michael Untch
Honoraria - Art tempi (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); MSD Oncology (Inst); Mundipharma (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche Pharma AG (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Lilly (Inst); MSD Oncology (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Frederik Marmé
No Relationships to Disclose
 
Jens Bodo Huober
Honoraria - Abbvie; AstraZeneca; Celgene; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Eisai; Hexal; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst); Hexal; Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; Novartis; Pfizer; Roche
 
Elmar Stickeler
Honoraria - AstraZeneca; Pfizer; Roche; Tesaro
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Mattea Reinisch
No Relationships to Disclose
 
Theresa Link
Honoraria - Amgen; Clovis Oncology; MSD; Novartis; Pfizer; Roche; Tesaro; Teva
Consulting or Advisory Role - Amgen; MSD; Roche; Tesaro
Travel, Accommodations, Expenses - Celgene; MSD; Pfizer; Roche
 
Bruno Valentin Sinn
No Relationships to Disclose
 
Jenny Furlanetto
No Relationships to Disclose
 
Toralf Reimer
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
 
Christine Solbach
Consulting or Advisory Role - Hologic; Olympus
Travel, Accommodations, Expenses - Dialog Service GmbH; German Breast Group; iMed Conference; Medconcept; Medtronic; Mentor; Mylan; Pfizer
 
Sabine Schmatloch
No Relationships to Disclose
 
Julia Rey
No Relationships to Disclose
 
Nicole Burchardi
No Relationships to Disclose
 
Sibylle Loibl
Honoraria - Chugai Pharma
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Immunomedics (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)